en ENGLISH
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
4/2022
vol. 97
 
Poleć ten artykuł:
Udostępnij:
Artykuł oryginalny

Analysis of blood count derivative parameters and selected biochemical and fibrinolysis parameters in children with urticaria

Anna Góra
1
,
Maciej Przybył
1
,
Majka Jaszczura
1
,
Małgorzata Morawiecka-Pietrzak
1
,
Edyta Machura
1

  1. Katedra i Klinika Pediatrii, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny, Katowice, Polska
Pediatr Pol 2022; 97 (4): 311-318
Data publikacji online: 2022/12/30
Plik artykułu:
- Analysis of blood.pdf  [0.17 MB]
Pobierz cytowanie
 
Metryki PlumX:
 

INTRODUCTION

Urticaria is a skin disease characterized by the presence of wheals, angioedema, or the coexistence of both symptoms [1]. Duration of skin lesions in acute urticaria (AU) does not exceed 6 weeks, whereas in chronic urticaria (CU) the lesions persist for more than 6 weeks [1]. Chronic urticaria can be classified as spontaneous urticaria (CSU) or as inducible urticaria – involving a specific triggering factor (e.g. cold, pressure, cholinergic stimulation) [1, 2]. Classified as spontaneous urticaria in some patients is associated with autoimmunity, however in most cases the cause of the disease remains unknown [3].
The development of urticaria depends on the activation of mast cells and other immune cells [4, 5]. As a result of the degranulation of skin mast cells, histamine and other inflammatory mediators are released, which initiates the disease process [4–6].
The histopathological features of urticaria are skin edema, capillary dilation, and the formation of perivascular infiltrates composed of CD4+ lymphocytes, monocytes, neutrophils, eosinophils, and basophils [4]. In AU, approximately one hour after the onset of the wheal, mainly neutrophils are present in the infiltrate [7, 8].
Infections are the most common identified cause of AU in children [9, 10]. More rarely, AU is associated with hypersensitivity reactions to food and drugs [2, 11]. The pathogenesis of CU is multifactorial, involving activation of the immune mechanisms and coagulation disorders [4, 10, 12, 13]. It has been demonstrated that up to 40% of patients with CSU shows a positive result of the autologous serum skin test (ASST) [7]. In patients with CSU, the presence of autoantibodies specific either for the high-affinity IgE receptor (FceRI) or for IgE is found [8]. Children and adults with AU and CU have increased levels of inflammatory markers and some coagulation markers, which are associated with the degree of disease activity [12, 14–16]. The white blood cells (WBC), neutrophil and lymphocyte count and neutrophil/lymphocyte ratio (NLR) are indicators of systemic inflammation. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio (PLR) and mean platelet volume/platelet count ratio (MPR) are markers that can be assessed easily and determine presence of systemic inflammatory response. These markers have been used to assess the severity of lesions in many diseases such as atopic dermatitis, IgA vasculitis, psoriasis, systemic lupus erythematosus, and cancer [17–21].
In the present study we evaluated selected blood morphology indices and their derivatives (NLR, PLR, MPR) as well as biochemical (C-reactive protein – CRP) and fibrinolysis (D-dimer) parameters in children with AU and CU to determine their usefulness in the assessment of disease occurrence and activity.

MATERIAL AND METHODS

Study population

The study included 125 children with urticaria: 76 subjects with AU and 49 subjects with CSU. Patients were hospitalized in 2013–2019. In each case the diagnosis of the disease was based on the EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria [1], which include presence of wheals, angioedema, or both in a determined time period: acute (≤ 6 weeks) or chronic (> 6 weeks). Urticaria activity was assessed using the total symptom score (TSS) [4, 22], which is defined as the sum of the scores for the number and size of wheals and severity of pruritus. The maximum diameter of the largest wheal was assessed according to the following scheme: 0 = 0, 1 = diameter ≤ 1.5 cm, 2 = diameter > 1.5 cm and ≤ 2.5 cm, 3 = diameter > 2.5 cm. The number of wheals was estimated consecutively as: 0 = no wheals, 1 ≤ 10 wheals, 2  10 wheals, 3 = body covered with wheals. Severity of pruritus was scored as: 0 = absent, 1 = mild pruritus, 2 = moderate with slight disturbance of daily activities and/or sleep, 3 = intense unbearable itching with marked disturbance of daily activities and/or sleep. The control group (CG) consisted of 75 healthy children, selected in terms of age and gender. Children included into the CG attended the outpatient pediatric clinic for nonimmunological, noninflammatory health problems and needed venous puncture.
Patients with diagnoses of sepsis, immunological disorders, hematological diseases, genetic syndromes and patients using antihistamine treatment or systemic corticosteroids prior to blood sampling were excluded from the study. Retrospective data on the course of the disease, anthropometric data and results of additional, including laboratory tests were collected.
Informed consent was obtained from all study participants and/or their parents. The presented study was approved by the Bioethics Committee of the Medical University of Silesia in Katowice on 26.02.2019 (decision no KNW/0022/KB1/6/I/19).

Laboratory analysis

Venous blood samples for laboratory tests were collected on admission to the ward, before the administration of drugs that may modify the course of the disease. Samples were tested within the first hour after collection. Citrate tubes were used for D-dimer analysis, blood for the remaining laboratory test was collected into EDTA tubes. Complete blood count was determined by an automated method using an ABX Pentra XL 80. All laboratory parameters were determined with respect to age standards.

Statistical data

Statistical evaluation was obtained using Statistica 13.1, Dell Inc. The descriptive statistical analysis was presented as median and quartiles (Q25–Q75). The Kruskall- Wallis test was used in the comparative analysis of groups, the normality of distribution was determined by Shapiro-Wilk test. Logistic regression analysis was performed to identify potential factors associated with the development of urticaria. The receiver operating curve (ROC) curve was determined to assess the sensitivity and specificity of analyzed variables. The correlation between the selected parameters was assessed using the Spearman’s rank test. P-values lower than 0.05 were considered significant.

RESULTS

There were no significant differences in terms of age, gender and body mass index between the patient with urticaria and CG. The median length of hospitalization for patients with AU was 5 days, for CU 4 days. Children with AU were the predominant group (n = 76; 60.8%). Chronic urticaria was diagnosed in 39.2% (n = 49) of patients. In the CU group, ASST positivity was present in 16% (n = 8) of patients. Detailed characteristics are presented in the Table 1.

Urticaria patients vs. control group

In patients with AU compared to CG, significantly higher values of WBC, NLR, neutrophil count, platelet count (PLT) and CRP were found (for WBC, NLR, neutrophil count and CRP p < 0.001; for PLT p = 0.01) (Table 2). Similarly, values of WBC, neutrophil count, PLT and CRP were significantly higher in patients with CU compared to the CG (for WBC, neutrophil count and CRP p < 0.001, for PLT p = 0.01). Taking into account the activity of the disease these differences were found only in patients with severe CU. C-reactive protein levels higher than normal (CRP serum concentration > 5 mg/l), were noted in 43.4% (n = 33) of patients with AU and in 24.5% (n = 12) of patients with CU.
In AU and CU significantly lower median MPR values were found as compared to the CG (patients with AU, CU, severe CU vs. control: p = 0.01; p = 0.01; p < 0.001 respectively). There were no significant differences between groups regarding levels of haemoglobin (Hgb), lymphocyte count, PLR, platelet distribution width and MPV.

Acute vs. chronic urticaria group

There were statistically significant higher values of WBC, NLR, neutrophil count, CRP and D-dimer in patients with AU compared to the CU (for WBC, NLR, neutrophil count, D-dimer p < 0.001; for CRP p = 0.01).

Mild course chronic urticaria vs. severe course chronic urticaria

There were significantly lower values of WBC, neutrophil count, NLR, PLT, CRP (p = 0.01; p < 0.001; p < 0.001; p = 0.02; p = 0.01) and significantly higher values of MPR (p = 0.02) in patients with mild CU vs. severe CU.

Moderate course chronic urticaria vs. severe course chronic urticaria

Patients with moderate CU compared to severe CU had significantly lower values of WBC, neutrophil count, NLR, MPV, PLT, CRP (p < 0.001; p < 0.001; p = 0.02; p = 0.04; p < 0.001; p < 0.05) and higher values of MPR (p < 0.001).

Additional results

In both patients with AU and CU, we confirmed a significant correlation between CRP levels and the value of NLR (r = 0.39, p < 0.001; r = 0.57, p < 0.001), neutrophil count (r = 0.47, p < 0.001, respectively; r = 0.38, p = 0.01) and D-dimer levels (r = 0.43, p < 0.001; r = 0.28, p < 0.05).
The duration of hospitalization in AU and CU patients positively correlated with CRP concentration (r = 0.43, p < 0.001; r = 0.38, p = 0.01, respectively). The disease activity assesed on the TSS scale in patients with AU positively correlated with the CRP concentration (r = 0.24, p = 0.04) and D-dimer levels (r = 0.28, p = 0.02). In CU, there was also a correlation between disease activity and CRP levels (r = 0.35, p = 0.01), WBC values (r = 0.30, p = 0.04) and NLR values (r = 0.44, p < 0.001).
Altogether in the group of patients with urticaria based on logistic regression analysis, it was found that the highest risk of developing urticaria is associated with elevated NLR, neutrophil count, WBC, CRP and D-dimer values (Table 3).
Receiver operating curve analysis revealed that statistically significant predictors of urticaria included D-dimer, WBC, NLR and CRP. The largest area under the curve (AUC) was demonstrated for D-dimer (AUC = 0.84; p < 0.001) (Fig. 1.) The optimal cut-off value for D-dimer determined by Youden index was 390.0. The parameter with the highest sensitivity (86%) turned out to be D-dimers, while the highest specificity (76%) was demonstrated for WBC (Table 4). In the logistic regression model and ROC analysis, the parameters PLT, MPV, MPR and PLR did not meet criteria for statistical significance, therefore they were not assessed as biomarkers of urticaria.

DISCUSSION

In this study, we found increased values of CRP, WBC and neutrophil count in patients with AU and severe CU in comparison to the CG.
Current reports indicate that patients with urticaria have elevated interleukin 6 (IL-6) levels [23]. In AU, there is an overproduction of IL-1, which stimulates the production of IL-6 and then acute phase proteins, including CRP [6]. According to Czarnecka-Operacz et al. in patients with AU, a severe course of the disease is associated with elevated serum CRP levels [4], a similar correlation was noted in our study. In the case of CU, regardless of its mechanism, significantly higher CRP values are found in comparison to the CG [4], similarly significantly higher CRP values are reported in patients with CSU poorly responsive to antihistamine treatment [23]. Receiver operating curve analysis showed moderate sensitivity and specificity (67% and 65%, respectively, cut-off 1.59) for CRP as an indicator of urticaria occurrence.
We also noted higher values of WBC, neutrophil count and NLR comparing patients with AU in relation to patients with CU, which may indicate a higher intensity of inflammation in the first group. In the ROC curve analysis, NLR and WBC, turned out to be moderately sensitive and specific in the prediction of urticaria (63% and 71%, cut-off 1.68 for the NLR; 62% and 76%, cut-off 9.16 for the WBC, respectively).
According to Antia et al., AU is associated with high leukocyte infiltration, leukocytosis and prolonged erythrocyte sedimentation rate [8]. Similar data were presented in the works of other authors [9, 24, 25]. The data we obtained are consistent with previous reports.
Considering the fact that infection is the most frequently documented cause of AU in children [3], identification of the cause of the increase in inflammatory and leukocyte parameters may pose difficulties. In our patients with urticaria, the development of urticarial lesions and the increase in WBC and NLR counts occurred independently of coexisting infection or allergy in an IgE-mediated mechanism. These indicate that up-regulation of CRP and IL-6 in urticaria/angioedema does not necessarily reflect a concomitant infection, but first of all points to high activity of the urticarial inflammation itself.
We observed significantly higher values of WBC and NLR in patients with severe CU in comparison with mild and moderate CU. It is believed that the development of urticaria depends on the migratory ability of immune cells determined by the interaction of chemotactic factors and endothelium. During this process, T lymphocytes, monocytes, eosinophils, and basophils move from the blood into tissues, leading to the formation of perivascular infiltrates [26]. According to Karaman et al, in CU, due to an inflammatory response, there is a shift in the leukocyte pool in the body, resulting in an increase in neutrophil and a decrease in lymphocyte count in the blood [23].
Neutrophils are an important link in the immune response primarily due to their production of reactive oxygen species, degranulation abilities, and formation of neutrophil extracellular traps (NETs); they also have a regulatory function for the acquired immune system [27]. Increased neutrophil count and NLR values are associated with poor prognosis in children with CSU. Previous literature reports [23] as well as our study in CU reveal a positive correlation between NLR value and activity of urticarial lesions. Additionally, we found a correlation between WBC value and CU activity. It is worth mentioning that the NLR was also found to be useful as a marker for the presence of psoriasis and exacerbation of atopic dermatitis [18, 28].
The increase in leukocyte parameters in children with urticaria and their usefulness in predicting the activity of changes found in our study seems to have multiple causes due to the aforementioned complex etiopathogenesis of individual clinical manifestations of urticaria. In addition, we should mention a number of factors affecting the values of leukocyte parameters such as medications (including corticosteroids, epinephrine, lithium, β-mimetics), physical stress (surgery, trauma, excessive exercise), emotional stress, necrotic and inflammatory foci, bone marrow diseases [29].
We noted an increase in platelet count among patients with AU and CU compared to controls and a higher PLT in patients with severe CU compared to patients with mild and moderate CU. It seems that platelet activation in this case may be related to the activation of proinflammatory mechanisms, especially IL-6 stimulating megakaryocyte proliferation [30] and activation of coagulation supporting mechanisms in inflamed vessels [31, 32].
Different results were obtained for the MPR parameter (MPV/PLT), which was significantly lower among children with AU and severe CU than in controls. The observed changes draw attention to the activation of the platelet system in the course of exacerbation of urticarial lesions, which in the case of our patients translated mainly into an increase in the number of PLT.
In previous reports lower MPV values were found in children with inflammatory diseases [24]. It is worth mentioning that in adult patients in contrast to children, elevated MPV values are usually observed in the course of CU [33]. Increased MPV has also been reported in patients with other skin diseases such as psoriasis, atopic eczema, and systemic lupus erythematosus (SLE) [19, 24].
The influence of genetic polymorphisms and variation of MPV with age, hormonal changes or lifestyle factors (smoking, obesity, hypertension, diabetes) should be considered in the evaluation of platelet parameters [30]. In our study, platelet parameter values proved to be useless as a predictor of urticarial lesion occurrence. Thus, there is a need for further studies in this regard.
We found significantly higher D-dimer levels among patients with AU compared to CU. Receiver operating curve analysis indicated that D-dimers were the best predictor of urticaria occurrence among the laboratory parameters tested (AUC = 0.84, sensitivity 86%, specificity 69%, cut-off 390.0). In addition, D-dimer levels correlated positively with disease activity in this group.
D-dimers are a fibrin degradation products formed by activation of the clotting cascade of blood and thrombin. Previously, elevated D-dimer levels have been found in patients with AU, including those requiring prolonged corticosteroid therapy [34]. According to Zhang et al. in AU there is an association of elevated D-dimers with the severity of skin lesions, moreover, high IgE levels may promote activation of the coagulation system in an extrinsic mechanism [35]. The development and severity of skin lesions have been shown to be related to thrombin production also in the case of CSU [32, 33, 36]. It is relevant that the absence of an increase in D-dimers plays an important role in excluding coagulation disorders [32].
A study by Kolkhir et al. in a group of patients with CSU reported a positive correlation between CRP levels and fibrinogen and D-dimer levels [37]. D-dimer levels also proved to be a significant marker of CSU activity among patients developing resistance to omalizumab treatment [38].
Inflammation is believed to be the link between the immune system and the coagulation system. Current reports indicate that CU is accompanied by systemic inflammation as well as activation of the coagulation and fibrinolysis systems [13–15].
It seems that in view of the complex pathomechanism of urticaria development, the parameters we analyzed in the study may constitute potential directions for further research. This study has several limitations. First of all, it is a single-center retrospective study with a limited number of patients, which may affect the quality of the obtained data. The used disease activity scale was selected as for adult patients; there is no standardized scale assessing both AU and CU activity.

CONCLUSIONS

Increased values of WBC, NLR, PLT, CRP and D-dimers, regardless of coexistence of infection, reflect the presence of inflammation and activation of fibrinolysis in children with urticaria. The utility of parameters calculated from blood count as well as biochemical and fibrinolysis parameters as biomarkers of urticaria activity requires further study.

ACKNOWLEDGMENTS

The study was financed by the funds of the Medical University of Silesia in Katowice for the development of young scientists and participants of doctoral studies at the scientific units (KNW-2-K37/D/9/N).

DISCLOSURE

The authors declare no conflicts of interest.

REFERENCES

1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international ACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022; 77: 734-766.
2. Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children – a systematic review on interventions and comorbidities. Pediatr Allergy Immunol 2018; 29: 303-310.
3. Shin M, Lee S. Prevalence and causes of childhood urticaria. Allergy Asthma Immunol Res 2017; 9: 189-190.
4. Czarnecka-Operacz M, Szulczyńska-Gabor J, Leśniewska K, et al. Acute-phase response and its biomarkers in acute and chronic urticaria. Postepy Dermatol Alergol 2018; 35: 400-407.
5. Papadopoulos J, Karpouzis A, Tentes J, Kouskoukis C. Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria. J Clin Med Res 2014; 6: 133-137.
6. Machura E, Szczepańska M, Mazur B, Barć-Czarnecka M, Kasperska- Zając A. Interleukin 1-β, interleukin-1 receptor antagonist, and interleukin 18 in children with acute spontaneous urticaria. Biomed Res Int 2013; 2013: 605262.
7. Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: an updated review of the pathogenesis and management. Pediatr Allergy Immunol 2019; 30: 17-24.
8. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up. J Am Acad Dermatol 2018; 79: 599-614.
9. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5: 10.
10. Góra A, Jaszczura M, Morawiecka-Pietrzak M, Kleszyk M, Machu- ra E. What do we currently know about urticaria in children? Pediatr Pol 2022; 97: 133-139.
11. Comert S, Celebioglu E, Karakaya G, Kalyoncu AF. The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria. Allergol Immunopathol (Madr) 2013; 41: 239-245.
12. Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol 2014; 28: 469-474.
13. Asero R, Tedeschi A, Marzano AV, Cugno M. Chronic urticaria: a focus on pathogenesis. F1000Res 2017; 11: 1095.
14. Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV. Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 2012; 10: 653-658.
15. Grzanka R, Damasiewicz-Bodzek A, Kasperska-Zajac A. Interplay between acute phase response and coagulation/fibrinolysis in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2018; 14: 27.
16. Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr 2019; 45: 101.
17. Peng W, Li C, Zhu WJ, et al. Prognostic value of the platelet to lymphocyte ratio change in liver cancer. J Surg Res 2015; 194: 464-470.
18. Paliogiannis P, Satta R, Deligia G, et al. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med 2019; 19: 37-45.
19. Yim JH, Park HJ, Cho SY, Shin MK. Mean platelet volume and mean platelet volume/platelet count ratio in chronic urticaria. Ann Dermatol 2019; 31: 467-469.
20. Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed) 2020; 16: 255-261.
21. Jaszczura M, Góra A, Grzywna-Rozenek E, Barć-Czarnecka M, Machura E. Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol Int 2019; 39: 869-878.
22. Lorette G, Giannetti A, Pereira RS, Leynadier F, Murrieta-Aguttes M. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group. J Eur Acad Dermatol Venereol 2000;14: 83-90.
23. Karaman S, Turedi B. Neutrophil-lymphocyte ratio: a possible marker of remission in children with chronic spontaneous urticaria. Allergol Immunopathol (Madr) 2020; 48: 290-294.
24. Akelma AZ, Mete E, Cizmeci MN, Kanburoglu MK, Malli DD, Bozkaya D. The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria. Allergol Immunopathol (Madr) 2015; 43: 10-13.
25. Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011; 41: 1386-1391.
26. Giménez-Arnau AM, DeMontojoye L, Asero R, et al. The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells. J Allergy Clin Immunol Pract 2021; 9: 2195-2208.
27. Li Y, Wang W, Yang F, Xu Y, Feng C, Zhao Y. The regulatory roles of neutrophils in adaptive immunity. Cell Commun Signal 2019; 17: 147.
28. Jiang Y, Ma W. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in atopic dermatitis patients. Med Sci Monit 2017; 23: 1340-1346.
29. Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician 2015; 92: 1004-1011.
30. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm 2019; 2019: 9213074.
31. Kasperska-Zając A, Grzanka A, Jarzab J, et al. The association between platelet count and acute phase response in chronic spontaneous urticaria. Biomed Res Int 2014; 2014: 650913.
32. Farres MN, Refaat M, Melek NA, Ahmed EE, Shamseldine MG, Arafa NA. Activation of coagulation in chronic urticaria in relation to disease severity and activity. Allergol Immunopathol (Madr) 2015; 43: 162-167.
33. Kolkhir P, André F, Church MK, Maurer M, Metz M. Potential blood biomarkers in chronic spontaneous urticaria. Clin Exp Allergy 2017; 47: 19-36.
34. Zaryczański J, Ochab A, Ochab M, Zaryczańska A, Brzoza Z, Chobot A. D-dimer concentrations in acute urticaria in children. Allergol Immunopathol (Madr) 2021; 49: 107-112.
35. Zhang Y, Zhang H, Du S, Yan S, Zeng J. Advanced biomarkers: therapeutic and diagnostic targets in urticaria. Int Arch Allergy Immunol 2021; 182: 917-931.
36. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-1117.
37. Kolkhir P, Altrichter S, Hawro T, Maurer M. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. Allergy 2018; 73: 940-948.
38. Asero R. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab. Clin Exp Dermatol 2017; 42: 667-669.
Copyright: © 2022 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
© 2024 Termedia Sp. z o.o.
Developed by Bentus.